Generation Bio Co reports results for the quarter ended in March - Earnings Summary

Generation Bio

13/05/2024 23:15

* Generation Bio Co  GBIO.OQ  reported a quarterly adjusted
loss
of $1.12​​ per share for the quarter ended in March, lower than
the same quarter last year, when the company reported EPS of -53
cents.  The mean expectation of seven analysts for the quarter
was for a loss of 41 cents per share. Wall Street expected
results to range from -57 cents to -27 cents per share.
    * Revenue was $4.06 million​; analysts expected $1.92
million. 
    * Generation Bio Co's reported EPS for the quarter was a
loss of
$1.12​.
    * The company reported a quarterly loss of $74.54 million.
    * Generation Bio Co shares had fallen by 26.5% this
quarter and
gained 81.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 6% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Generation Bio Co
is $7.50 
This summary was machine generated from LSEG data May 13 at
10:14 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.41          -1.12          Missed
 Dec. 31 2023      -0.45          -0.53          Missed
 Sep. 30 2023      -0.50          -0.43          Beat
 Jun. 30 2023      -0.50          -0.47          Beat